IX BIOPHARMA LTD.
🇸🇬Singapore
- Country
- 🇸🇬Singapore
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- 68
- Market Cap
- -
- Website
- http://www.ixbiopharma.com
Study of Wafermineâ„¢ for Post-bunionectomy or Abdominoplasty Pain
Phase 2
Completed
- Conditions
- AbdominoplastyAcute PainBunion
- Interventions
- Drug: PlacebosDrug: Wafermineâ„¢ 50 mgDrug: Wafermineâ„¢ 75 mgDrug: Wafermineâ„¢ 25 mg
- First Posted Date
- 2017-08-11
- Last Posted Date
- 2018-07-23
- Lead Sponsor
- iX Biopharma Ltd.
- Target Recruit Count
- 125
- Registration Number
- NCT03246971
- Locations
- 🇺🇸
Lotus Clinical Research, Pasadena, California, United States
Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols.
- First Posted Date
- 2016-08-05
- Last Posted Date
- 2016-08-19
- Lead Sponsor
- iX Biopharma Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT02857361
- Locations
- 🇦🇺
Linear Clinical Research, Nedlands, Western Australia, Australia
A Pivotal Study of the Bioequivalence of Oral Viagra® and a Test Sublingual Sildenafil Wafer
Phase 3
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- First Posted Date
- 2016-08-01
- Last Posted Date
- 2016-08-19
- Lead Sponsor
- iX Biopharma Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT02850718
- Locations
- 🇦🇺
Linear Clinical Research, Perth, Western Australia, Australia
A Study Of The Effectiveness Of Wafermine Alone And In Combination With Opioids In Subjects Undergoing Bunionectomy
- First Posted Date
- 2015-09-04
- Last Posted Date
- 2016-02-23
- Lead Sponsor
- iX Biopharma Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT02541396
- Locations
- 🇺🇸
Jean Brown Research, Salt Lake City, Utah, United States
Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction
- First Posted Date
- 2015-02-06
- Last Posted Date
- 2015-03-26
- Lead Sponsor
- iX Biopharma Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT02356965
- Locations
- 🇺🇸
Jean Brown Research, Salt Lake City, Utah, United States
Study of Ketamine Administered Intravenously and by Sublingual Wafer
Completed
- Conditions
- Pain
- First Posted Date
- 2011-06-21
- Last Posted Date
- 2015-03-10
- Lead Sponsor
- iX Biopharma Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT01377831
- Locations
- 🇦🇺
Pain and Anaesthesia Research Clinic (PARC), Royal Adelaide Hospital, Adelaide, South Australia, Australia
© Copyright 2025. All Rights Reserved by MedPath